While some studies indicate that a decrease in RUNX1 signaling is indicative of increased cell death and diminished lymphocyte proliferation, which would correlate with late stage EVD’s characteristic lymphopenia, there is evidence that the opposite can also be true (Korinfskaya et al., 2021). This evidence concerns the gene RUNX1 and lymphopenia.